Robertson N, Deans J, Fraser M, Compston D A
Neurology Unit, University of Cambridge.
J Epidemiol Community Health. 1996 Jun;50(3):274-9. doi: 10.1136/jech.50.3.274.
To establish an updated prevalence and incidence figure for multiple sclerosis on 1 July 1993, to determine the fate of the 374 patients prevalent in 1990, and to establish the origin of incident patients.
Case ascertainment was from several sources including departmental records, local branches of the Multiple Sclerosis Society, general practitioners, nursing homes, and residential facilities for the disabled. Data collection was by personal interview using a standardised questionnaire and by retrospective analysis of departmental case notes. A prospective incidence register of newly diagnosed patents was maintained from 1990.
The Cambridge Health District of East Anglia covering 340,910 hectares in area and a population of 290,700.
Altogether 441 patients prevalent on 1 July 1993 were identified, of whom 328 were contacted so that clinical data could be collected. Seventy patients (16%) either declined to take part or access was denied by their general practitioner; 8 (2%) had died; and 35 (8%) were too ill or failed to respond to several requests for contact.
A comprehensive re-evaluation of the south Cambridgeshire multiple sclerosis register revealed a prevalence of 441/290,700 population (152/10(5)) for all disease classifications on 1 July 1993. This represented an increase of 18% from 1990 and was a result of 138 additions and 71 deletions from the original list of 374 patients. The sex ratio of prevalent patients was 2.6 F:M, the mean age at disease onset was 31.7 years, and the mean age was 49 years. Mortality for 1990-93 was 3.3/10(5)/year and prospective maintenance of an incidence register recorded 96 new diagnoses for all classifications of multiple sclerosis over the five year period 1990-94 (6.6/10(5)/year).
The increase in prevalence mainly resulted from improved case ascertainment identifying a further 58 patients who had been prevalent in 1990. Comparisons with other serial studies within the United Kingdom show similarities in proportional increase with successive studies indicating that serial survey may in part account for the observed latitudinal gradient within the United Kingdom. However, the observed prevalence (152/10(5)) in this second survey still falls short of the figure estimated from incidence and mortality data (186/10(5)).
确定1993年7月1日多发性硬化症的最新患病率和发病率,判定1990年已患该病的374例患者的转归情况,并确定新发病例的来源。
病例确定来自多个渠道,包括科室记录、多发性硬化症协会当地分会、全科医生、疗养院以及残疾人居住设施。通过使用标准化问卷进行个人访谈以及对科室病例记录进行回顾性分析来收集数据。自1990年起维持新诊断患者的前瞻性发病率登记册。
东盎格鲁的剑桥健康区,面积340,910公顷,人口290,700。
共识别出1993年7月1日患多发性硬化症的441例患者,其中328例接受了联系以便收集临床数据。70例患者(16%)拒绝参与或其全科医生拒绝提供信息;8例(2%)已死亡;35例(占8%)病情过重或经多次联系仍无回应。
对剑桥郡南部多发性硬化症登记册进行全面重新评估后发现,1993年7月1日所有疾病分类的患病率为441/290,700人口(152/10⁵)。这比1990年增加了18%,原因是在最初的374例患者名单中新增了138例,剔除了71例。现患患者的性别比为女性∶男性 = 2.6∶1,发病时的平均年龄为31.7岁,平均年龄为49岁。1990 - 1993年的死亡率为3.3/10⁵/年,前瞻性发病率登记册记录在1990 - 1994年这五年期间所有类型的多发性硬化症有96例新诊断病例(6.6/10⁵/年)。
患病率的增加主要是由于病例确定方法改进,又识别出了1990年就已患病的58例患者。与英国境内其他系列研究相比,相继研究中的比例增长具有相似性,这表明系列调查可能部分解释了在英国观察到的纬度梯度现象。然而,第二次调查中观察到的患病率(152/10⁵)仍低于根据发病率和死亡率数据估算的数值(186/10⁵)。